BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16637072)

  • 1. Germline ATBF1 mutations and prostate cancer risk.
    Xu J; Sauvageot J; Ewing CM; Sun J; Liu W; Isaacs SD; Wiley KE; Diaz L; Zheng SL; Walsh PC; Isaacs WB
    Prostate; 2006 Jul; 66(10):1082-5. PubMed ID: 16637072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations of the MSR1 gene in prostate cancer families from Germany.
    Maier C; Vesovic Z; Bachmann N; Herkommer K; Braun AK; Surowy HM; Assum G; Paiss T; Vogel W
    Hum Mutat; 2006 Jan; 27(1):98-102. PubMed ID: 16287155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
    Wang X; Wang F; Taniguchi K; Seelan RS; Wang L; Zarfas KE; McDonnell SK; Qian C; Pan K; Lu Y; Shridhar V; Couch FJ; Tindall DJ; Beebe-Dimmer JL; Cooney KA; Isaacs WB; Jacobsen SJ; Schaid DJ; Thibodeau SN; Liu W
    Cancer Res; 2006 Nov; 66(21):10302-7. PubMed ID: 17079449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.
    Sun X; Frierson HF; Chen C; Li C; Ran Q; Otto KB; Cantarel BL; Vessella RL; Gao AC; Petros J; Miura Y; Simons JW; Dong JT
    Nat Genet; 2005 Apr; 37(4):407-12. PubMed ID: 15750593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the BRG1 gene in prostate cancer clinical samples.
    Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
    Int J Oncol; 2003 May; 22(5):1003-7. PubMed ID: 12684665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.
    Bevan S; Edwards SM; Ardern Jones A; Dowe A; Southgate C; Dearnaley D; Easton DF; Houlston RS; Eeles RA;
    Prostate Cancer Prostatic Dis; 2003; 6(1):12-4. PubMed ID: 12664059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
    Lindmark F; Jonsson BA; Bergh A; Stattin P; Zheng SL; Meyers DA; Xu J; Grönberg H
    Prostate; 2004 May; 59(2):132-40. PubMed ID: 15042613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients.
    Gómez-Zaera M; Abril J; González L; Aguiló F; Condom E; Nadal M; Nunes V
    Mutat Res; 2006 Mar; 595(1-2):42-51. PubMed ID: 16472830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of HPC2/ELAC2 in hereditary prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of germline alteration of MSR1 with prostate cancer risk.
    Wang L; McDonnell SK; Cunningham JM; Hebbring S; Jacobsen SJ; Cerhan JR; Slager SL; Blute ML; Schaid DJ; Thibodeau SN
    Nat Genet; 2003 Oct; 35(2):128-9. PubMed ID: 12958598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.
    Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
    J Urol; 2004 Jan; 171(1):431-3. PubMed ID: 14665948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
    Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
    Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalent mutations in prostate cancer.
    Dong JT
    J Cell Biochem; 2006 Feb; 97(3):433-47. PubMed ID: 16267836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.
    Mononen N; Syrjäkoski K; Matikainen M; Tammela TL; Schleutker J; Kallioniemi OP; Trapman J; Koivisto PA
    Cancer Res; 2000 Nov; 60(22):6479-81. PubMed ID: 11103816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.
    Solé X; Hernández P; de Heredia ML; Armengol L; Rodríguez-Santiago B; Gómez L; Maxwell CA; Aguiló F; Condom E; Abril J; Pérez-Jurado L; Estivill X; Nunes V; Capellá G; Gruber SB; Moreno V; Pujana MA
    BMC Genomics; 2008 Jan; 9():12. PubMed ID: 18190704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
    Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi OP; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
    Nat Genet; 2002 Feb; 30(2):181-4. PubMed ID: 11799394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.